Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
23,630 total articles
Bridger Aerospace announced a strategic partnership with OroraTech USA to incorporate OroraTech's satellite-based wildfire detection, thermal mapping, and fire spread simulation data into Bridger's IGNIS wildfire operations platform. This integration will enhance real-time situational awareness for wildfire agencies and improve decision-making duri…
Mint Incorporation Limited announced a binding consulting agreement with CURRENC Capital to support the issuer-sponsored tokenization of a portion of its Nasdaq-listed Class A ordinary shares on the Ethereum and Solana blockchains. This initiative aims to modernize share ownership records and enhance shareholder engagement while continuing traditio…
Altimmune, Inc., a late clinical-stage biopharmaceutical company focused on serious liver diseases, announced that its management will participate in a fireside chat at the Wells Fargo 21st Annual Healthcare Conference. The discussion will highlight the company's lead candidate, pemvidutide, which targets metabolic and alcohol-related liver disease…
Microchip Technology, a US semiconductor supplier, partners with global automotive supplier Marelli to pioneer an open-standard connectivity solution, ASA Motion Link (ASA-ML), for streaming video and graphics from vehicle central computers to automotive displays. This collaboration aims to simplify vehicle display architectures, reduce costs, and …
Digital Realty appoints Guilherme Reis as Managing Director for Iberia to oversee operations and growth in Spain and Portugal. Reis will lead the company's expansion efforts including new developments in Madrid, Barcelona, and entry into Lisbon, positioning Iberia as a strategic digital infrastructure hub for the Mediterranean region amid rising cl…
Quince Therapeutics will participate in major healthcare investor conferences in September 2026 to discuss the development progress of its lead drug candidate, LAM-001, targeting serious pulmonary diseases. The company is advancing multiple Phase 2 clinical trials and aims to provide disease-modifying therapies for underserved conditions.
NANO Nuclear Energy Inc. announced significant progress in the development of the primary helium circulator for its KRONOS MMR Energy System, achieving an engineering milestone by advancing from preliminary engineering to detailed design in partnership with Howden, a Baker Hughes business. This collaboration enhances the foundation for the commerci…
Krystal Biotech announced its participation in the 2026 Cantor Global Healthcare Conference where management will conduct a fireside chat and investor meetings. The company, a commercial-stage biotech specializing in genetic medicines, aims to showcase its innovative therapies such as VYJUVEK® and its growing pipeline to potential investors.
LB Pharmaceuticals has appointed Joseph Miller as Chief Financial Officer. Miller brings over 20 years of biopharmaceutical finance experience, including successful commercialization of a novel therapy. His expertise aims to support LB Pharmaceuticals as it approaches critical Phase 3 trial results for LB-102, a potential first benzamide antipsycho…
Tectonic Therapeutic, Inc., a clinical-stage biotechnology company specializing in therapeutic proteins and antibodies targeting GPCRs, announced that its CEO, Alise Reicin, will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference. The event will provide insights into the company's proprietary GEODe platfor…
Jyong Biotech Ltd., a Nasdaq-listed biotechnology company focused on plant-derived therapeutics for urinary system diseases, announced its participation in the StockFan Virtual Investor Non-Deal Roadshow scheduled for September 6-7, 2026. The event aims to engage investors, analysts, and media across multiple time zones with presentations in both M…
Kustom Entertainment, Inc. provided a detailed operational update on its pending acquisition of TFL, LLC (Tickets For Less), highlighting TFL's diversified and high-margin revenue streams exceeding $238 million in 2025. The integration is expected to unify ticketing infrastructure with Kustom's TicketSmarter platform, internalize ticketing margins …
Satellogic has announced that all maritime intelligence derived from its upcoming Merlin satellite constellation will be exclusively distributed through SynMax's Theia platform. The Merlin constellation, launching in October 2026, offers daily global coverage at one-meter resolution to enhance vessel detection, dark-vessel identification, sanctions…
Stereotaxis' Genesis Robotic Magnetic Navigation system was used to treat over 70 arrhythmia patients at the University of Szeged within one month of launching their robotic cardiology program, marking Hungary's first such program and demonstrating rapid adoption and advanced treatment capabilities.
3 E Network Technology Group Limited announced a $1 million private placement led by its CEO, Dr. Tingjun Yang, to strengthen its AI strategy. The capital will support ongoing R&D and commercialization of AI computing chips and applications. Recent milestones include advancements in edge AI SoCs, cloud AI storage controllers, a green AI data center…
AGM Group Holdings Inc. announced that their full-stack AI storage solutions are gaining market traction, driven by rising demand for high-performance data storage used in large AI model R&D and cloud services. The company has started mass production of all-flash servers and has secured procurement agreements with enterprise and regional computing …
Emergent BioSolutions has completed a repurchase of $75 million aggregate principal amount of its 3.875% Senior Unsecured Notes due 2028, reducing the outstanding debt balance to approximately $364.7 million. The company executed this repurchase at an average price of 90.6% of face value, deploying about $68 million of cash, demonstrating disciplin…
Hillman Solutions Corp., a leading hardware product provider, has completed its acquisition of Kanebridge, LLC, a master distributor of industrial fasteners, for approximately $315 million. This strategic move significantly expands Hillman's industrial addressable market to around $3 billion and establishes its first U.S. master distribution platfo…
Helus Pharma announced that CEO Michael Halstead will participate in a fireside chat at the 2026 Cantor Global Healthcare Conference in New York. The company is advancing its clinical-stage programs for proprietary serotonergic agonists aimed at treating depression and anxiety, including a Phase 3 candidate with FDA Breakthrough Therapy Designation…
The FDA has granted Fast Track designation to Liquidia Corporation's inhaled powder drug YUTREPIA (treprostinil) for the treatment of Raynaud's phenomenon associated with systemic sclerosis (SSc-RP), a condition with significant unmet medical need and no approved therapies in the United States. This designation will help expedite the development an…
Crescent Biopharma, a clinical-stage biotech company focusing on innovative cancer therapies, announced its management will present at the 2026 Cantor Global Healthcare Conference and Morgan Stanley Global Healthcare Conference in September. The presentations will highlight the company's pipeline developments including a PD-1 x VEGF bispecific anti…
Structure Therapeutics, a clinical-stage biopharmaceutical company focused on oral small molecule therapeutics for metabolic diseases, will participate in three leading healthcare investment conferences in September 2026, including Cantor Global Healthcare, Morgan Stanley Global Healthcare, and Bernstein’s Healthcare Forum. Management will hold fir…
TG Therapeutics announced that CEO Michael S. Weiss will participate in a fireside chat at the Cantor Global Healthcare Conference on September 9, 2026. The company is a commercial-stage biotech focused on treatments for B-cell diseases, with its FDA-approved drug BRIUMVI for relapsing multiple sclerosis.
Rekor Systems, Inc. has terminated its two remaining long-term real estate leases in the US and Israel, resulting in elimination of ongoing rent obligations and generating over $2 million in annual cost savings. The company used $2.8 million in cash to reduce $10 million in lease liabilities, improving operating leverage and aligning cost structure…
Electra Battery Materials Corporation is progressing with the construction of Canada’s only cobalt sulfate refinery in Ontario as part of its strategic plan to strengthen North America's critical minerals supply chain. The company is actively engaging with investors, industry participants, and government bodies through multiple September conference…
